On May 3, 2018 Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, reported that Louis Matis, Senior Vice President and Chief Development Officer of Pieris Pharmaceuticals, Inc., will present at the 43rd Annual Deutsche Bank Healthcare Conference on Tuesday, May 8, 2018 at 8:00AM EDT at the Intercontinental Boston Hotel in Boston, Massachusetts. A webcast of the company’s presentation will be available at this link (Press release, Pieris Pharmaceuticals, MAY 3, 2018, View Source [SID1234526085]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!